Sign in Subscribe
Infection

Sensitive Near Point-of-Care Detection of Malaria Offers Scalable Solution for Elimination in Africa

Strategic Insights

— 1 min read

Researchers from Imperial College London have developed a near point-of-care, LAMP-based diagnostic platform for malaria diagnosis using capillary blood. This platform has shown high sensitivity and specificity in detecting Plasmodium falciparum infections, including asymptomatic and submicroscopic cases, in African endemic countries. The study's findings have significant implications for malaria elimination efforts in Africa.

Key Takeaways:

  • The research team adapted a LAMP-based diagnostic platform for malaria diagnosis using capillary blood, which meets the Malaria Eradication Research Agenda (malERA) criteria for community-level screening.
  • The platform achieved 95.2% sensitivity and 96.8% specificity in detecting P. falciparum infections, including 94.9% of asymptomatic infections and 95.3% of submicroscopic cases.
  • The diagnostic method offers a sensitive, scalable solution to support test-and-treat strategies for malaria elimination across Africa.
  • The research was supported by Wellcome Trust, DH | NIHR | Programme Development Grants, Jameel Fund for Infectious Disease Research and Innovation, and the Fleming Initiative at Imperial College London.
  • The study evaluated the performance of the platform on 672 capillary blood samples collected at the community level in The Gambia and Burkina Faso.

Statistics:

  • 672 capillary blood samples were evaluated in the study.
  • 146 P. falciparum positives were confirmed by qPCR.
  • 130/137 asymptomatic infections were detected by the platform.
  • 41/43 submicroscopic cases were detected by the platform.
  • The platform achieved a sample-to-result time under 45 minutes.
  • The limit of detection of the platform was 0.6 parasites/mL.

Sources:

  • Sensitive near point-of-care detection of asymptomatic and submicroscopic Plasmodium falciparum infections in African endemic countries. Nature Communications, 2025;16(1):8925.
  • Nature Portfolio, Heidelberger Platz 3, Berlin, 14197, Germany.
  • NewsRx. Researchers at Imperial College London Target Malaria (Sensitive near point-of-care detection of asymptomatic and submicroscopic Plasmodium falciparum infections in African endemic countries). Health & Medicine Week. October 24, 2025; p 57.

Read more